International Study With Nexavar About Safety and Efficacy in Carcinoma Hepatocellular Therapy (HCC)

Trial Profile

International Study With Nexavar About Safety and Efficacy in Carcinoma Hepatocellular Therapy (HCC)

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Jul 2017

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Acronyms INSIGHT
  • Sponsors Bayer
  • Most Recent Events

    • 11 Jul 2017 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research.
    • 24 Sep 2014 According to a Bayer HealthCare media release, results from this trial will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress.
    • 13 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top